why novartis� landmark cancer drug approval is great news for bluebird http://lm360.us/Sevy-sister-of-Stilphen-from-Huisnes?Cosnerfat=78
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .